News and Blog
Welcome to your information hub to keep up to date with our latest news, product launches, industry insights, case studies and much more.
View all blogs:
Croda breaks ground on new manufacturing facility for pharmaceutical excipients in Lamar, Pennsylvania
31st May 2023: Croda, Inc., the company that uses smart science to create high-performance ingredients and solutions that improve lives, broke ground on 9 May 2023, its newest manufacturing facility...
From Triton X-100 to Virodex: exploring our innovative solution to the Triton X-100 ban
For those who have previously relied on Triton™ X-100 as a surfactant or detergent in their manufacturing processes there is now an urgent need to find a suitable replacement. Explore Croda's...
Croda announces two new partnerships to drive sustainable delivery systems for the pharmaceutical industry
19 May 2023: Croda International Plc (Croda) today announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain...
The future of mRNA delivery: Advancements in engineering lipid nanoparticles for enhanced intracellular delivery through inhalation
Messenger RNA (mRNA) has played a crucial role in recent vaccine developments and is at the forefront of much current medical research. Traditionally. the delivery of mRNA systemically via lipid...
Oral Drug Delivery
The oral route of administration presents a convenient, cost-effective, and non-invasive method for delivering drugs. However, with the increasing complexity of APIs, the delivery of these drugs also...
Revolutionizing gene editing: How RGD peptide-based lipids could be the key to effective mRNA delivery
Gene editing has emerged as a promising strategy for treating a wide range of genetic disorders. However, the efficacy of gene therapy is limited by the challenge of delivering therapeutic agents to...
Precision medicine revolution: The potential of DSPE-RGD in targeted drug delivery
In recent years, researchers and clinicians have been exploring new ways to deliver drugs directly to the cells and tissues that need them, while minimizing side effects on healthy cells. One of the...
Promising new results for metastatic prostate cancer vaccine
A new study1 published in Frontiers in Immunology reports promising vaccine results for patients with hormone-sensitive prostate cancer. The researchers demonstrated that a vaccine formulation...
Lipids in Small-Molecule Pro-Drugs
Lipids are used in therapeutics in many ways. Some lipids have even been used as small-molecule drugs to treat specific diseases, and are also being used to improve undesirable characteristics of...
Our veterinary health offering
We are the global partner for high quality excipients, adjuvant systems and formulation support for the animal health industry, and we are continuously innovating to provide break-through solutions...
Croda Pharma welcomes Dave Cherry
We warmly welcome Dave Cherry as our new Global Managing Director. David brings with him past experiences from his work with the wider Life Sciences Leadership Team and healthcare markets, which is...
Introducing our Adjuvant Systems Platform
Introducing our Adjuvant Systems platform. Leveraging a history of developing adjuvants since 1939, our scientists deliver high performance adjuvants to meet your vaccine needs today.
Introducing our Nucleic Acid Delivery platform
This post introduces our Nucleic Acid Delivery platform, a technology area that was strengthened through our acquisition of Avanti Polar Lipids in 2020.
Croda Pharma: The future of novel excipients
The importance of excipients and their specialised role in formulation development has been recognised in recent years, whether that be for targeting delivery of the drug, aesthetics of the final...
Expert Q&A - Dr Stephen Rumbelow:
Formulating a drug for parenteral delivery comes with its fair set of challenges. Aside from a high level of sensitivity to external factors like light and heat exposure, these large and complex drugs...
Lipid technology for delivery of gene editing therapies
Gene-editing is one of the most eagerly anticipated biopharma developments in recent history. However, one of the biggest hurdles to the development of successful gene-editing therapeutics is...
Excipient sustainability - A user and a supplier perspective
To achieve their sustainability ambitions excipient users need to access excipients produced with lower embedded GHG emissions, little or no waste produced and with minimal impact on water quality and...
Things to consider when choosing a cationic lipid for your formulation
Lipid-based therapeutic delivery systems have been evolving for many years. From delivering naked mRNA, to using liposomes, and now lipid nanoparticles,
Innovative lipids for your nucleic acid delivery research
Lipid-based therapeutic delivery systems have been evolving for many years. From delivering naked mRNA, to using liposomes, and now lipid nanoparticles,
Introducing our Small Molecule Delivery platform
Our offering for Small Molecule Delivery focuses on tackling your formulation challenges and enhancing drug delivery through our high purity Super Refined™ excipients. Over the years, enhancing...
Lets connect...
Register to the mailing list to unlock:
- First access to new products, new data and exclusive literature
- Whitepapers and thought provoking content
- Special offers on conference and exhibition passes when available
- Invitations to invite only Croda Pharma events.